Natixis Investment Managers International’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,069
Closed -$27K 235
2022
Q3
$27K Hold
1,069
﹤0.01% 226
2022
Q2
$35K Sell
1,069
-1,932
-64% -$82.1K ﹤0.01% 475
2022
Q1
$216K Buy
3,001
+1,747
+139% +$126K ﹤0.01% 425
2021
Q4
$115K Buy
1,254
+548
+78% +$65.5K 0.01% 196
2021
Q3
$89K Sell
706
-43
-6% -$6.26K 0.01% 200
2021
Q2
$124K Sell
749
-20
-3% -$3.24K 0.01% 199
2021
Q1
$139K Sell
769
-31
-4% -$7.19K 0.01% 199
2020
Q4
$159K Buy
+800
New +$163K 0.01% 203

Other funds holding TDOC

Natixis Investment Managers International's TDOC Position: Q4 2022 in Review

Natixis Investment Managers International sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 1,069 shares — an estimated $27K sold.

Natixis Investment Managers International first reported a position in TDOC in Q4 2020 and held it in 8 quarters. The position peaked at $216K in Q1 2022. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Natixis Investment Managers International reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 1,069 Teladoc Health shares in Q4 2022, an estimated $27K.
  • Natixis Investment Managers International first reported a position in Teladoc Health in Q4 2020 and held it in 8 quarters.
  • Natixis Investment Managers International's Teladoc Health position peaked at $216K in Q1 2022.
  • 445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Natixis Investment Managers International's 13F filing for Q4 2022, filed 13 Feb 2023.